Related references
Note: Only part of the references are listed.Cancer Statistics, 2021
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells
Wenbin Xu et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2021)
Downregulation of RAGE Inhibits Cell Proliferation and Induces Apoptosis via Regulation of PI3K/AKT Pathway in Cervical Squamous Cell Carcinoma
Ruyi Li et al.
ONCOTARGETS AND THERAPY (2020)
METTL3 regulates the malignancy of cervical cancer via post-transcriptional regulation of RAB2B
Yingying Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
METTL3 potentiates resistance to cisplatin through m6A modification of TFAP2C in seminoma
Jingchao Wei et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Roles of METTL3 in cancer: mechanisms and therapeutic targeting
Chengwu Zeng et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer
Huan-he Ni et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification
Qianqing Wang et al.
CELL DEATH & DISEASE (2020)
Development and Validation of an m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction in Cervical Squamous Cell Carcinoma
Jingxin Pan et al.
FRONTIERS IN ONCOLOGY (2020)
The mechanism of m6A methyltransferase METTL3-mediated autophagy in reversing gefitinib resistance in NSCLC cells by β-elemene
Shuiping Liu et al.
CELL DEATH & DISEASE (2020)
Discovery of Small Molecules that Activate RNA Methylation through Cooperative Binding to the METTL3-14-WTAP Complex Active Site
Simona Selberg et al.
CELL REPORTS (2019)
Where, When, and How: Context-Dependent Functions of RNA Methylation Writers, Readers, and Erasers
Hailing Shi et al.
MOLECULAR CELL (2019)
m6A mRNA methylation initiated by METTL3 directly promotes YAP translation and increases YAP activity by regulating the MALAT1-miR-1914-3p-YAP axis to induce NSCLC drug resistance and metastasis
Dan Jin et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
AGEs, RAGEs and s-RAGE; friend or foe for cancer
Saheem Ahmad et al.
SEMINARS IN CANCER BIOLOGY (2018)
Concurrent chemoradiotherapy vs. radiotherapy alone in locally advanced cervix cancer: A systematic review and meta-analysis
Niloy Ranjan Datta et al.
GYNECOLOGIC ONCOLOGY (2017)
Reduced m6A mRNA methylation is correlated with the progression of human cervical cancer
Xiuli Wang et al.
ONCOTARGET (2017)
Breaking the DNA damage response to improve cervical cancer treatment
Hylke W. Wieringa et al.
CANCER TREATMENT REVIEWS (2016)
A METTL3-METTL14 complex mediates mammalian nuclear RNA N6-adenosine methylation
Jianzhao Liu et al.
NATURE CHEMICAL BIOLOGY (2014)
N6-Methyladenosine in nuclear RNA is a major substrate of the obesity-associated FTO
Guifang Jia et al.
NATURE CHEMICAL BIOLOGY (2011)
HMGB1 and RAGE in Inflammation and Cancer
Gary P. Sims et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Fueling inflammation at tumor microenvironment: the role of multiligand/rage axis
Armando Rojas et al.
CARCINOGENESIS (2010)
Understanding RAGE, the receptor for advanced glycation end products
A Bierhaus et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Share Paper
